Lonza Group Stock Performance
LZAGF Stock | USD 589.25 1.55 0.26% |
The company secures a Beta (Market Risk) of 0.28, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Lonza Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding Lonza Group is expected to be smaller as well. At this point, Lonza Group has a negative expected return of -0.14%. Please make sure to verify Lonza Group's value at risk, rate of daily change, relative strength index, as well as the relationship between the kurtosis and market facilitation index , to decide if Lonza Group performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Lonza Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical and fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
Begin Period Cash Flow | 495 M | |
Total Cashflows From Investing Activities | 1 B |
Lonza |
Lonza Group Relative Risk vs. Return Landscape
If you would invest 65,900 in Lonza Group on August 29, 2024 and sell it today you would lose (7,130) from holding Lonza Group or give up 10.82% of portfolio value over 90 days. Lonza Group is currently producing negative expected returns and takes up 2.6821% volatility of returns over 90 trading days. Put another way, 23% of traded pink sheets are less volatile than Lonza, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
Lonza Group Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lonza Group's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Lonza Group, and traders can use it to determine the average amount a Lonza Group's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0535
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | LZAGF |
Estimated Market Risk
2.68 actual daily | 23 77% of assets are more volatile |
Expected Return
-0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Lonza Group is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lonza Group by adding Lonza Group to a well-diversified portfolio.
Lonza Group Fundamentals Growth
Lonza Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Lonza Group, and Lonza Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lonza Pink Sheet performance.
Return On Equity | 0.12 | |||
Return On Asset | 0.057 | |||
Profit Margin | 0.20 % | |||
Operating Margin | 0.25 % | |||
Current Valuation | 36.21 B | |||
Shares Outstanding | 74.19 M | |||
Price To Earning | 41.63 X | |||
Price To Book | 3.37 X | |||
Price To Sales | 6.17 X | |||
Revenue | 5.41 B | |||
EBITDA | 1.36 B | |||
Cash And Equivalents | 2.44 B | |||
Cash Per Share | 32.76 X | |||
Total Debt | 2.23 B | |||
Debt To Equity | 0.24 % | |||
Book Value Per Share | 142.97 X | |||
Cash Flow From Operations | 1.22 B | |||
Earnings Per Share | 13.23 X | |||
Total Asset | 16.46 B | |||
Retained Earnings | 2.28 B | |||
Current Asset | 1.93 B | |||
Current Liabilities | 1.3 B | |||
About Lonza Group Performance
By analyzing Lonza Group's fundamental ratios, stakeholders can gain valuable insights into Lonza Group's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Lonza Group has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Lonza Group has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia and New Zealand, and internationally. The company was founded in 1897 and is headquartered in Basel, Switzerland. Lonza operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 17154 people.Things to note about Lonza Group performance evaluation
Checking the ongoing alerts about Lonza Group for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Lonza Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Lonza Group generated a negative expected return over the last 90 days |
- Analyzing Lonza Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lonza Group's stock is overvalued or undervalued compared to its peers.
- Examining Lonza Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lonza Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lonza Group's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lonza Group's pink sheet. These opinions can provide insight into Lonza Group's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Lonza Pink Sheet analysis
When running Lonza Group's price analysis, check to measure Lonza Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lonza Group is operating at the current time. Most of Lonza Group's value examination focuses on studying past and present price action to predict the probability of Lonza Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lonza Group's price. Additionally, you may evaluate how the addition of Lonza Group to your portfolios can decrease your overall portfolio volatility.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies |